Evidence map›Paper›PMID 29333430›Full record

ArticleJournal of fungi (Basel, Switzerland)2017

Adaptive Immunity to

Liliane Mukaremera, Kirsten Nielsen

Open access · goldAbstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. The hypervirulent Type-1/Type-17 phenotype ofInfection and immunity · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. State of the Field: Cytotoxic Immune Cell Responses inJournal of fungi (Basel, Switzerland) · 2024
    Review
  16. Article
  17. Review
  18. Immune evasion byFrontiers in immunology · 2024
    Article
  19. Global trends inFrontiers in immunology · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Liliane MukaremeraDepartment of Microbiology and Immunology, Medical School, University of Minnesota, 689 23rd Ave SE, Minneapolis, MN 55455, USA.
Kirsten NielsenDepartment of Microbiology and Immunology, Medical School, University of Minnesota, 689 23rd Ave SE, Minneapolis, MN 55455, USA.
University of Minnesota Medical Center · US

Funding

Pheromones and Titan Cell Production in Cryptococcus neoformansR01AI080275 · NIAID · UNIVERSITY OF MINNESOTA · PI NIELSEN, KIRSTEN · 2011 to 2015
$1.8M
Control of cryptococcal infection through manipulation of the host immune response.R21AI122352 · NIAID · UNIVERSITY OF MINNESOTA · PI NIELSEN, KIRSTEN · 2016 to 2017
$419k
NIAID NIH HHS R01 AI080275NIAID NIH HHS R21 AI122352
6 · The paper itself

Abstract

The

Indexed as

adaptive immunityCD4Cryptococcuscytokinesdendritic cellshelper T cell type 17 (Th17)helper T cell type 1 (Th1)helper T cell type 2 (Th2)immune reconstitution inflammatory syndrome (IRIS)

Identifiers

PMID29333430
PMCPMC5753166
OpenAlexW2768674794

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.